102 related articles for article (PubMed ID: 26270779)
1. The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis.
Koster RA; Alffenaar JW; Botma R; Greijdanus B; Uges DR; Kosterink JG; Touw DJ
Bioanalysis; 2015; 7(14):1717-22. PubMed ID: 26270779
[TBL] [Abstract][Full Text] [Related]
2. The performance of five different dried blood spot cards for the analysis of six immunosuppressants.
Koster RA; Botma R; Greijdanus B; Uges DR; Kosterink JG; Touw DJ; Alffenaar JW
Bioanalysis; 2015; 7(10):1225-35. PubMed ID: 26045003
[TBL] [Abstract][Full Text] [Related]
3. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
Koster RA; Alffenaar JW; Greijdanus B; Uges DR
Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
[TBL] [Abstract][Full Text] [Related]
4. Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption.
Hempen CM; Maarten Koster EH; Ooms JA
Bioanalysis; 2015; 7(16):2019-29. PubMed ID: 26327182
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry.
den Burger JC; Wilhelm AJ; Chahbouni A; Vos RM; Sinjewel A; Swart EL
Anal Bioanal Chem; 2012 Oct; 404(6-7):1803-11. PubMed ID: 22899246
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
[TBL] [Abstract][Full Text] [Related]
7. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots.
Klak A; Pauwels S; Vermeersch P
Diagnosis (Berl); 2019 Mar; 6(1):57-68. PubMed ID: 30808156
[TBL] [Abstract][Full Text] [Related]
8. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots.
Deprez S; Heughebaert L; Boffel L; Stove CP
Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
[TBL] [Abstract][Full Text] [Related]
10. A volumetric absorptive microsampling LC-MS/MS method for five immunosuppressants and their hematocrit effects.
Koster RA; Niemeijer P; Veenhof H; Hateren KV; Alffenaar JC; Touw DJ
Bioanalysis; 2019 Mar; 11(6):495-508. PubMed ID: 30892068
[No Abstract] [Full Text] [Related]
11. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
Meinitzer A; Gartner G; Pilz S; Stettin M
Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots.
Li Q; Cao D; Huang Y; Xu H; Yu C; Li Z
Biomed Chromatogr; 2013 Mar; 27(3):327-34. PubMed ID: 22893355
[TBL] [Abstract][Full Text] [Related]
13. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement.
den Burger JC; Wilhelm AJ; Chahbouni AC; Vos RM; Sinjewel A; Swart EL
Anal Bioanal Chem; 2015 Jan; 407(2):621-7. PubMed ID: 25374126
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring.
Dickerson JA; Sinkey M; Jacot K; Stack J; Sadilkova K; Law YM; Jack RM
Pediatr Transplant; 2015 Feb; 19(1):101-6. PubMed ID: 25414084
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
Hinchliffe E; Adaway JE; Keevil BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
[TBL] [Abstract][Full Text] [Related]
16. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
Becker S; Thiery J; Ceglarek U
Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
[TBL] [Abstract][Full Text] [Related]
19. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
20. Validation of a dried blood spot LC-MS/MS approach for cyclosporin A in cat blood: comparison with a classical sample preparation.
Mohamed R; Mercolini L; Cuennet-Cosandey S; Chavent J; Raggi MA; Peyrou M
J Pharm Biomed Anal; 2012 Jul; 66():298-305. PubMed ID: 22522039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
